|
AU2490102A
|
|
Method for diagnosing a tumor in a patient determining the concentration of pibf
|
|
AU2171302A
|
|
Modified phage, comprising a non-lytic modification and expressing a kil-gene
|
|
WO0232451A1
|
|
Vaccine composition comprising an antigen and a peptide having adjuvant properties
|
|
WO0193905A1
|
|
Immunostimulatory oligodeoxynucleotides
|
|
ATA1302001A
|
|
Method for identifying, isolating and producing antigens against a specific pathogen
|
|
ATA10372000A
|
|
Vector and a method for the expression and selection of randomized peptide sequences
|
|
ATA10002000A
|
|
Antique composition
|
|
ATA9612000A
|
|
Method for screening and isolating microorganisms, in particular prokaryontic and eukaryontic cells that present an antique
|
|
ATA6452000A
|
|
Method for identifying cytokin secretry cells
|
|
ATA1292000A
|
|
Pharmaceutical composition for immunulating and producing vaccines
|
|
ATA168099A
|
|
Pharmaceutical composition containing an antig
|
